BRD6688
CAS No. 1404562-17-9
BRD6688 ( —— )
Catalog No. M23563 CAS No. 1404562-17-9
BRD6688 is a selective HDAC2 inhibitor that acts by enhancing the learning and memory processes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 260 | In Stock |
|
10MG | 461 | In Stock |
|
25MG | 750 | In Stock |
|
50MG | 1035 | In Stock |
|
100MG | 1395 | In Stock |
|
500MG | 2673 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBRD6688
-
NoteResearch use only, not for human use.
-
Brief DescriptionBRD6688 is a selective HDAC2 inhibitor that acts by enhancing the learning and memory processes.
-
DescriptionBRD6688 is a selective HDAC2 inhibitor that acts by enhancing the learning and memory processes
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC1;HDAC2;HDAC3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1404562-17-9
-
Formula Weight282.3
-
Molecular FormulaC16H18N4O
-
Purity>98% (HPLC)
-
Solubilityethanol:≤2mg/ml;DMSO:30mg/ml;dimethyl formamide:30mg/ml
-
SMILESC1CCN(C1)C(=O)NC2=C(C=CC(=C2)C3=CC=NC=C3)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers[J]. Chemical Science, 2014, 6(1):804-815.
molnova catalog
related products
-
Pyroxamide
Pyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
-
SR-18292
SR-18292 is a PPAR gamma coactivator-1α (PGC-1α) inhibitor, which increases PGC-1α acetylation, suppresses gluconeogenic gene expression and reduces glucose production in hepatocytes.
-
Ledipasvir
Ledipasvir is a Hepatitis C Virus NS5A Inhibitor. The mechanism of action of ledipasvir is as a P-Glycoprotein Inhibitor, and Breast Cancer Resistance Protein Inhibitor.